黄酮类化合物市场－全球产业规模、份额、趋势、机会及预测（按类型、应用、形态、地区和竞争格局划分，2021-2031年）

全球类黄酮市场预计将从 2025 年的 16.2 亿美元成长到 2031 年的 22.9 亿美元，复合年增长率为 5.94%。

黄酮类化合物是一类用途广泛的多酚类次级代谢物，广泛存在于植物中，它们不仅是重要的色素，还具有优异的抗氧化功效。推动该市场成长的主要因素是文明病慢性疾病发病率的上升以及消费者对天然预防保健方式的明显偏好。此外，黄酮类化合物在医药和食品行业中作为天然色素和功能性成分的日益广泛应用，也为这一积极的市场趋势提供了有力支撑。

然而，该行业在健康声明的复杂法规结构和植物萃取物的标准化方面面临着许多挑战。各地不同的品管通讯协定和严格的核准程序可能会阻碍这些产品的顺利商业分销。儘管监管复杂，市场需求依然强劲。根据美国植物委员会 (ABC) 2024 年的报告，美国草药膳食补充剂的零售额达到了创纪录的 132.3 亿美元。这项数据凸显了天然化合物巨大的商业性潜力，并显示儘管面临监管挑战，消费者对天然化合物的兴趣仍持续高涨。

市场驱动因素

消费者对机能性食品和强化饮料的需求不断增长，这主要得益于人们对健康营养的日益重视。这一趋势促使製造商改进产品配方，添加植物性生物活性化合物，以提供抗氧化功效，同时保持洁净标示的完整性。植物性食品协会于2024年4月发布的《2023年市场报告》重点阐述了这种向天然成分转变的经济影响。报告显示，美国植物性食品的零售额达81亿美元。这一可观的数字表明，消费者群体愿意为天然产品买单，这直接惠及了为这些强化产品提供所需植物营养素的类黄酮供应链。

慢性病发病率的上升趋势推动了膳食补充剂的普及，同时也确立了类黄酮作为预防保健方法中重要成分的地位。随着文明病发病率的增加，旨在减少发炎和氧化压力的富含多酚的补充剂的消费量也相应增加。为了凸显这项健康紧迫性，美国癌症协会于2024年1月发布的《2024年癌症事实与数据》报告估计，美国新增癌症病例将达到2,001,140例，强调了治疗和预防措施的重要性。这项负担正在推动市场成长，负责任营养委员会（CRN）在2024年10月进行的一项调查发现，75%的美国成年人表示使用膳食补充剂，这表明这些成分拥有巨大的市场潜力。

市场挑战

全球类黄酮市场的扩张受到许多因素的显着限制，包括复杂的健康声明法规环境以及萃取物缺乏标准化。由于类黄酮植物来源，因此在不同批次的产品中保持化学成分和活性成分含量的一致性面临着巨大的科学挑战。这种差异性使得监管核准更加复杂，主要市场的监管机构要求提供严谨的证据来支持其功能性声明。缺乏标准化的临床级数据往往限制了製造商做出具体疗效声明的能力，从而限制了他们产品差异化以及向潜在客户传达产品价值的能力。

对可靠、检验的健康声明的限製造成了行业能力与消费者接受度之间的差距。当企业因法律原因无法详细说明富含类黄酮产品的特定预防功效时，潜在买家不太可能意识到自身的需求。这种犹豫不决反映在近期消费者数据中：2024 年责任营养委员会 (CRN) 的一项调查发现，41% 的膳食补充剂非使用者表示「不觉得有必要」​​是他们不服用膳食补充剂的主要原因。这项发现凸显了监管对健康讯息的限制如何将很大一部分人群拒之门外，从而阻碍了此类产品更广泛的商业性应用。

市场趋势

一个显着的行业趋势是将类黄酮融入抗衰老和光防护肤产品中，利用其中和自由基和减少紫外线引起的皮肤损伤的能力。化妆品研发人员正越来越多地将白藜芦醇、儿茶素和槲皮素等化合物添加到高级精华液中，以满足消费者对临床级植物来源美容解决方案的需求。这种对局部外用药妆品的探索，建立了一个有别于传统口服补充剂的高价值品类，并推动了对能够穿透皮肤屏障的高纯度萃取物的需求。该领域的经济实力显而易见。根据欧莱雅集团于2024年2月发布的2023年度报告，该公司皮肤科美容部门的同店销售额成长了28.4%，超过了整体美容市场的成长速度。这项结果证实了消费者对富含活性成分的健康护肤品的强劲需求。

同时，随着食品饮料生产商积极减少人工添加剂的使用，原料供应链也正在经历一场变革，合成色素也逐渐被花青素取代。花青素是一种类黄酮，能够产生红色、紫色和蓝色的植物色素，其应用日益广泛，不仅因为其抗氧化特性，更因为其作为一种稳定、天然的合成色素替代品，尤其可以替代红色40号等合成染料。这种转变体现了「洁净标示」的趋势，迫使供应商提高从接骨木莓和黑胡萝卜等原料中的提取能力，以满足工业规模的需求。 GNT集团于2024年4月发布的《2023年永续发展报告》揭示了这项变化的规模。报告显示，自2020年以来，该公司植物来源色素EXBERRY全球销售量的成长超过50%，显示该产业正持续向类黄酮色素转型。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球类黄酮市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依类型（花青素、黄酮、异黄酮、黄烷-3-醇、黄酮醇、花黄素、其他）
  • 依应用领域（机能饮料、机能性食品、营养补充品等）
  • 依型态（粉末与液体）
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美类黄酮市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲类黄酮市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区类黄酮市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲类黄酮市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章 南美洲类黄酮市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球类黄酮市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Cayman Chemical Company
• Quercegen Pharmaceutical
• Foodchem International Corporation
• INDOFINE Chemical Company, Inc.
• Toroma Organics Ltd
• Pharmachem Laboratories Inc.
• Organic Herb Inc.
• Phytocompounds
• Indena SpA
• Merck KGaA

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Flavonoid Market is projected to expand from USD 1.62 billion in 2025 to USD 2.29 billion by 2031, registering a compound annual growth rate of 5.94%. Flavonoids, a versatile group of polyphenolic secondary metabolites found abundantly in plants, function as vital pigments and offer substantial antioxidant benefits. The market is primarily propelled by the rising incidence of chronic lifestyle-related disorders and a decisive consumer shift toward natural preventive healthcare options. Additionally, the growing utilization of these substances as natural coloring agents and functional components within the pharmaceutical and food industries actively sustains this positive market trajectory.

However, the industry faces substantial obstacles regarding the intricate regulatory framework for health claims and the standardization of botanical extracts. Varying quality control protocols and rigorous approval procedures across different territories can hinder the smooth commercial distribution of these goods. Despite these regulatory complexities, market demand remains resilient; the American Botanical Council reported in 2024 that retail sales of herbal dietary supplements in the United States hit a historic high of 13.23 billion dollars. This statistic highlights the robust commercial potential for natural compounds, indicating that consumer interest persists even amidst regulatory challenges.

Market Driver

The escalating consumer demand for functional foods and fortified beverages serves as a major market accelerator, as individuals increasingly prioritize nutrition for health enhancement. This movement compels manufacturers to modify product formulations by including bioactive plant compounds that provide antioxidant advantages while maintaining clean-label integrity. The economic significance of this transition toward natural ingredients is highlighted by the Plant Based Foods Association's April 2024 "2023 State of the Marketplace" report, which noted that U.S. retail sales of plant-based foods totaled 8.1 billion dollars. This substantial figure indicates a consumer demographic ready to spend on natural formulations, thereby directly benefiting the flavonoid supply chain that furnishes the necessary phytonutrients for these enhanced products.

The rising prevalence of chronic illnesses is concurrently boosting the adoption of nutraceuticals, establishing flavonoids as essential components in preventive healthcare approaches. As the frequency of lifestyle-associated conditions grows, there is a corresponding rise in the intake of polyphenol-dense supplements designed to reduce inflammation and oxidative stress. Highlighting this health urgency, the American Cancer Society's "Cancer Facts & Figures 2024," released in January 2024, estimated 2,001,140 new cancer cases in the United States, emphasizing the critical need for therapeutic and preventative measures. This burden supports market growth, a fact reinforced by the Council for Responsible Nutrition's October 2024 survey, where 75% of U.S. adults reported using dietary supplements, illustrating the vast potential market for these ingredients.

Market Challenge

The expansion of the Global Flavonoid Market is significantly hindered by a complicated regulatory environment regarding health claims and a lack of extract standardization. Since flavonoids originate from a wide variety of botanical sources, maintaining consistent chemical profiles and potency levels across different production batches presents a considerable scientific challenge. This variability complicates regulatory approvals, as authorities in key markets demand rigorous proof to substantiate functional ingredient claims. In the absence of standardized, clinical-grade data, manufacturers are often barred from asserting specific therapeutic benefits, which restricts their capacity to distinguish their offerings and convey their value to potential customers.

This restriction on making robust, verified health claims fosters a gap between industry capabilities and consumer uptake. When companies are legally prevented from detailing the specific preventative advantages of flavonoid-rich products, prospective buyers often fail to see the necessity of the purchase. This hesitation is reflected in recent consumer data; according to the Council for Responsible Nutrition in 2024, 41 percent of non-users identified a lack of perceived need as their main reason for shunning dietary supplements. This finding underscores how regulatory constraints on health messaging contribute to keeping a large segment of the population out of the market, effectively impeding wider commercial adoption.

Market Trends

A prominent trend shaping the industry is the incorporation of flavonoids into anti-aging and photoprotective skincare products, leveraging their ability to neutralize free radicals and reduce UV-related skin damage. Cosmetic developers are increasingly blending compounds like resveratrol, catechins, and quercetin into advanced serums to meet consumer desires for clinical-grade, plant-based beauty solutions. This move into topical cosmeceuticals establishes a high-value sector separate from conventional oral supplements, fueling the need for high-purity extracts that can penetrate the skin barrier. The economic strength of this focus is evident; L'Oreal Group's "Annual Report 2023," published in February 2024, revealed that their Dermatological Beauty Division saw like-for-like sales grow by 28.4 percent, surpassing the general beauty market and validating the strong consumer demand for active, health-oriented skincare ingredients.

Concurrently, the substitution of synthetic colorants with anthocyanins is transforming the ingredient supply chain as food and beverage producers aggressively remove artificial additives. Anthocyanins, a flavonoid subclass that gives plants their red, purple, and blue colors, are being adopted not only for their antioxidant properties but primarily as stable, natural replacements for synthetic dyes such as Red 40. This transition operationalizes the clean label trend, compelling suppliers to increase extraction capacities from sources like elderberries and black carrots to satisfy industrial volume demands. The magnitude of this shift is highlighted by GNT Group's April 2024 "Sustainability Report 2023," which noted that global sales of their plant-based EXBERRY colors have risen by over 50 percent since 2020, signaling a lasting shift toward flavonoid-based pigmentation in the industry.

Key Market Players

• Cayman Chemical Company
• Quercegen Pharmaceutical
• Foodchem International Corporation
• INDOFINE Chemical Company, Inc.
• Toroma Organics Ltd
• Pharmachem Laboratories Inc.
• Organic Herb Inc.
• Phytocompounds
• Indena S.p.A
• Merck KGaA

Report Scope

In this report, the Global Flavonoid Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Flavonoid Market, By Type

• Anthocyanin
• Flavones
• Isoflavones
• Flavan-3-ols
• Flavonol
• Anthoxanthin
• Others

Flavonoid Market, By Application

• Functional Beverages
• Functional Food
• Dietary Supplements
• Others

Flavonoid Market, By Form

• Powder Vs Liquid

Flavonoid Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Flavonoid Market.

Available Customizations:

Global Flavonoid Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Flavonoid Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Anthocyanin, Flavones, Isoflavones, Flavan-3-ols, Flavonol, Anthoxanthin, Others)
  • 5.2.2. By Application (Functional Beverages, Functional Food, Dietary Supplements, Others)
  • 5.2.3. By Form (Powder Vs Liquid)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Flavonoid Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By Form
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Flavonoid Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Form
  • 6.3.2. Canada Flavonoid Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Form
  • 6.3.3. Mexico Flavonoid Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Form

7. Europe Flavonoid Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By Form
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Flavonoid Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Form
  • 7.3.2. France Flavonoid Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Form
  • 7.3.3. United Kingdom Flavonoid Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Form
  • 7.3.4. Italy Flavonoid Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Form
  • 7.3.5. Spain Flavonoid Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Form

8. Asia Pacific Flavonoid Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By Form
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Flavonoid Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Form
  • 8.3.2. India Flavonoid Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Form
  • 8.3.3. Japan Flavonoid Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Form
  • 8.3.4. South Korea Flavonoid Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By Form
  • 8.3.5. Australia Flavonoid Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By Form

9. Middle East & Africa Flavonoid Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By Form
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Flavonoid Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Form
  • 9.3.2. UAE Flavonoid Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Form
  • 9.3.3. South Africa Flavonoid Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Form

10. South America Flavonoid Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By Form
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Flavonoid Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Form
  • 10.3.2. Colombia Flavonoid Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Form
  • 10.3.3. Argentina Flavonoid Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Form

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Flavonoid Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Cayman Chemical Company
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Quercegen Pharmaceutical
• 15.3. Foodchem International Corporation
• 15.4. INDOFINE Chemical Company, Inc.
• 15.5. Toroma Organics Ltd
• 15.6. Pharmachem Laboratories Inc.
• 15.7. Organic Herb Inc.
• 15.8. Phytocompounds
• 15.9. Indena S.p.A
• 15.10. Merck KGaA

16. Strategic Recommendations

17. About Us & Disclaimer